Skip to Content

130 (Mycophenolate mofetil 250 mg)

This pill with imprint "130" is Blue & White, Capsule-shape and has been identified as Mycophenolate mofetil 250 mg. It is manufactured by Zydus Pharmaceuticals.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; pulmonary fibrosis; myasthenia gravis; systemic lupus erythematosus; autoimmune hepatitis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mycophenolate mofetil 250 mg 130
Discount Card Promo
Mycophenolate mofetil
Imprint:
130
Strength:
250 mg
Color:
Blue & White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Zydus Pharmaceuticals
National Drug Code (NDC):
68382-0130
Inactive Ingredients:
croscarmellose sodium
FD&C Blue No. 1
FD&C Red No. 3
magnesium stearate
gelatin
sodium lauryl sulfate
titanium dioxide
povidone k90
pregelatinized corn starch
silicon dioxide

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide